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ABSTRACT
Cord blood is widely used as surrogate tissue in epigenome-wide association studies of prenatal conditions. Cell
type composition variation across samples can be an important confounder of epigenome-wide association
studies in blood that constitute a mixture of cells. We evaluated a newly developed cord blood reference panel
to impute cell type composition from DNA methylation levels, including nucleated red blood cells (nRBCs). We
estimated cell type composition from 154 unique cord blood samples with available DNA methylation data as
well as direct measurements of nucleated cell types. We observed high correlations between the estimated and
measured composition for nRBCs (rD 0.92, R2D 0.85), lymphocytes (rD 0.77, R2D 0.58), and granulocytes (rD
0.72, R2 D 0.52), and a moderate correlation for monocytes (r D 0.51, R2 D 0.25) as well as relatively low root
mean square errors from the residuals ranging from 1.4 to 5.4%. These results validate the use of the cord blood
reference panel and highlight its utility and limitations for epidemiological studies.
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Introduction
Cord blood is widely used as a surrogate tissue in epidemiological
studies of prenatal, maternal, and environmental conditions, as it is
easily accessible at birth. Cord blood DNA methylation is of high
interest because it has the potential to reflect early life epigenetic
programming events that occur during embryogenesis. The study
of DNA methylation in blood or cord blood presents a particular
challenge as aggregate DNA methylation measures reflect a mix-
ture of different cell types, primarily leukocytes. To overcome this
challenge, statistical methods have been developed to estimate cell
type distributions from genome-wide DNA methylation arrays
using reference panels from isolated cell types.1 Epigenome-wide
association studies in blood have capitalized on thismethod to infer
white blood cell composition using an existing reference panel of
isolated leukocytes.2 Although this panel consists of 6 different leu-
kocytes (CD4C T-cells, CD8C T-cells, NK-cells, B-cells, monocytes
and granulocytes) they were isolated from 6 adult males, which
might not accurately represent cell type composition or methyla-
tion profiles of nucleated cells found in cord blood.
Recently, a panel of nucleated cell types isolated from cord
blood samples of males and female newborns was developed.3 Of
particular interest in the cord blood panel is the isolation and
characterization of DNAmethylation of nucleated red blood cells
(nRBCs), commonly present in cord blood but not adult blood.4
However, this panel has not been benchmarked against direct cell
count measurements in newborn cord blood. Previous studies of
cord blood DNAmethylation have used the adult leukocyte DNA
methylation reference panel to infer cell type composition, but
the performance of the adult reference panel for inferring white
blood cell composition of cord blood has shown limited utility.5
In the current report, we evaluated the performance of the
cord and adult blood reference panels for estimating cell type
distributions and compare them to direct cell count measure-
ments of cord blood leukocytes and nRBCs from a birth cohort
of 154 mother-child pairs. We further assessed the performance
for predicting cell type composition of all the normalization
methods available in the minfi bioconductor package used for
the analysis of DNA methylation arrays.6 Lastly, we also evalu-
ated the impact of adjusting for cell estimates using the 2 differ-
ent panels or the directly measured cell types in an epigenome-
wide association of gestational age at birth.
Results
A total of 154 cord blood samples were available for the valida-
tion of the estimated cell counts. Mothers were on average 28 y
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of age at the time of enrollment. About half of newborns were
female (55.2%) and almost all were from European descent
(99%)(Table 1). From the direct clinical measurement of cell
types, granulocytes were the most abundant cell type found in
cord blood, constituting on average 52.9% [standard deviation
(SD) D 7.8] of the nucleated cell types, followed by lympho-
cytes (mean D 31.3%; SD D 7.2), and monocytes (mean D
10.5%; SD D 2.3). Of the measured cell types in cord blood,
nRBCs were the least abundant, constituting on average 5.4%
(SD D 3.6) across samples.
We observed moderate to high correlation between the mea-
sured and estimated nucleated cell types using the recently pub-
lished reference cord blood panel.3 Namely, a high level of
correlation was observed between measured and estimated
nRBCs (r D 0.92, R2 D 0.85), lymphocytes (r D 0.77, R2 D
0.58), and granulocytes (r D 0.72, R2 D 0.52). A moderate cor-
relation was observed for monocytes (r D 0.51, R2 D 0.25). We
also observed relatively low root mean square errors (rMSE) of
the residuals for nRBCs (rMSE D 1.4%), lymphocytes (rMSE D
4.6%), granulocytes (rMSE D 5.4%), and monocytes (rMSE D
2.0%). Linear regression model prediction summaries are pre-
sented in Table 2 and Fig. 1.
Using the adult reference panel to estimate cord blood, leuko-
cyte composition yielded similar results with slightly lower correla-
tions observed for lymphocytes (rD 0.69, R2D 0.47), granulocytes
(r D 0.68, R2 D 0.46), and monocytes (r D 0.44, R2 D 0.19) com-
pared to the estimates obtained from the cord blood reference
panel. The rMSE of the residuals were slightly larger when the adult
reference panel was used, ranging from 2.1 to 5.7% (Table 2).
Although we observed relative high correlation between the
measured and estimated nucleated cell types, using either the
adult or cord reference panels, the actual predicted distribution
of estimated cell types differed, compared to clinically mea-
sured values (Table 2 and Fig. 2). Furthermore, different nor-
malization procedures yielded similar results in terms of
prediction, but slightly different estimates for the distribution
of cell types (Table 3 and Fig. 2). Changing the size of the CpG
libraries to include more cell type specific probes (up to 1000
CpGs), selecting both hyper- and hypo-methylated probes, or
selecting discriminatory probes based on F-statistic in the cell
estimation algorithm did not impact the results (data not
shown).
Finally, we performed an epigenome-wide association analy-
sis of gestational age at birth within our cohort to evaluate the
impact of model performance after adjusting for cell type com-
position using the directly measured cell types, the adult refer-
ence panel or the cord blood reference panel. After adjusting
for child sex and estimated leukocyte composition using the
adult reference panel, the genomic inflation factor (λ) was 1.27
in our cohort. The genomic inflation factor was reduced to 1.04
when adjusting for child sex and nucleated cell types, including
nRBCs, estimated from the cord blood reference panel. In a
similar model adjusted for the directly measured cell types
(lymphocytes, monocytes, nRBCs, neutrophils, eosinophils,
and basophils) the genomic inflation factor was 1.15. The
expected null distribution of P values was better approximated
when models were adjusted for the directly measured cell type
composition or using the cord blood estimates compared to the
adult reference panel (Fig. 3 and supplementary Fig. 1). Using a
Bonferroni adjusted threshold for statistical significance
(P < 1.02 £ 10¡7), 11 CpGs were associated with gestational
age after adjusting for the directly measured cell type composi-
tion, 34 CpGs were associated with gestational age after adjust-
ing for nucleated cells estimated from the cord blood reference
panel, and 35 CpGs were found using the adult reference panel
adjustment. All of the 11 CpGs found after adjusting for the
directly measured cell types were also present and consistent in
the direction of association after adjustment of nucleated cells
estimated from the cord blood reference panel. However, none
of these 11 CpGs reached Bonferroni significance in models
adjusted for leukocyte composition using the adult blood
reference panel. There was no overlap among the Bonferroni
significant CpGs found in models adjusted for cell type
composition using the cord or the adult blood reference panels.
Discussion
The present study evaluates the performance of the newly
developed cord blood reference panel for estimating nucleated
cell types from DNA methylation data available on commonly
used genome-wide arrays. We observed moderate to high
Table 1. Sample characteristics for the Gen3G birth cohort used for validation.
Sample Characteristic (n D 154) Mean (SD) or n (%)
Maternal Characteristics
Nulliparous 75 (48.7%)
Age (years) 28.2 (4.1)
Child Characteristics
Birth weight (grams) 3,400 (436)
Gestational age at birth (weeks) 39.4 (1.2)
Female 85 (55.2%)
European descent 152 (99%)
Table 2. Measured and predicted proportions of nucleated cell types using the cord blood reference panel and the adult blood reference panel in the Gen3G birth cohort
(nD 154).
Direct measurements Cord blood reference panel Adult blood reference panel
Nucleated Cell Type Mean (SD) Mean (SD) r R2 rMSE Mean (SD) r R2 rMSE
nRBCs 5.4% (3.6) 12.2% (3.9) 0.92 0.85 1.4% NA NA NA NA
Lymphocytes 31.3% (7.2) 46.4% (9.6) 0.77 0.58 4.6% 45.1% (9.0) 0.69 0.47 5.2%
Granulocytes 52.9% (7.8) 39.2% (10.4) 0.72 0.52 5.4% 49.3% (8.0) 0.68 0.46 5.7%
Monocytes 10.5% (2.3) 9.6% (2.5) 0.51 0.25 2.0% 11.8% (2.6) 0.44 0.19 2.1%
NA: not available.
r: correlation coefficient.
R2: coefficient of determination.
rMSE: root mean square error for the residuals from the linear regression model.
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Figure 1. Scatter plots and linear regression line for the comparison of the measured (y-axis) and estimated (x-axis) nucleated cell type composition from the cord blood
reference panel.
Figure 2. Distributions for the nucleated cell types directly measured in cord blood (red) and the estimates obtained from the cord blood reference panel using the raw
DNA methylation data and 5 different normalization methods.
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degree of co-variation between the estimated and measured cell
types in our validation set. We further observed improvement
of the genomic inflation factor in the epigenome-wide associa-
tion analysis for gestational age using the cord blood reference
panel to adjust for nucleated cell types in linear regression
models. However, the absolute cell type distributions differed
considerably between the estimated and measured cell types.
The current methodology may be sufficient to estimate relative
cell type amounts to control for cell type variation in epidemio-
logical studies, but caution should be used when using the
imputed white blood cell composition to make quantitative
inferences about immunological parameters in cord blood.
The measured nucleated cell type distribution in our cohort
is within previously reported reference ranges for cord blood,
suggesting that our results may be generalizable to other
cohorts. For example, mean nRBC abundance (nRBCs/100
WBCs) has been previously reported to vary between 4.1–9.2%
depending on gestational age and sex of the newborn, and val-
ues between 0 to 10% are considered normal.4,7 This is consis-
tent with the mean measured nRBC composition of 5.4% in
our study. Granulocytes represented the majority of measured
cell types in our sample (mean D 52.9%), consistent with a
previous study of 120 healthy newborns where mean cord
blood granulocytes (basophils, eosinophils, neutrophils) were
reported to be approximately 54.7% of the nucleated cell types.8
Our direct measurements of lymphocytes (mean D 31.3%) and
monocytes (mean D 10.5%) were also within agreement with a
previous study of 120 healthy newborns were lymphocytes and
monocytes were estimated to constitute 35.9 and 8.9% of the
nucleated cells in cord blood, respectively.8 The highest correla-
tion and smallest rMSE for the residuals were observed for the
comparison of estimated and measured nRBCs. This might be
attributed to the fact that discriminatory probes for inferring
nRBCs are distinctly hypomethylated (>99 %) compared to all
other cell types, highlighting the unique methylation signature
of nRBCs.3
Although high correlations between measured and predicted
nucleated cell type composition were observed, the current esti-
mation method over-predicts the abundance of lymphocytes
and nucleated red blood cells. The estimated proportion of
granulocytes was under-predicted. We explored several alterna-
tives to correct for this bias, including multiple normalization
processes, selecting more discriminatory probes, and selecting
probes based on F-statistic rather than P value. However, none
Table 3. Evaluation of normalization methods for the prediction of nucleated cell types in cord blood using the cord blood reference panel, compared to the complete
blood count measured cell types in the Gen3G birth cohort (n D 154).
Raw data Illumina (Studio) Noob (Default) FunNorm Quantile SWAN
Cell types r R2 rMSE r R2 rMSE r R2 rMSE r R2 rMSE r R2 rMSE r R2 rMSE
nRBCs 0.92 0.84 1.4% 0.93 0.87 1.3% 0.92 0.85 1.4% 0.92 0.85 1.3% 0.86 0.73 1.9% 0.92 0.84 1.4%
Lymphocytes 0.76 0.58 4.7% 0.76 0.58 4.7% 0.77 0.58 4.6% 0.77 0.59 4.6% 0.75 0.55 4.8% 0.76 0.58 4.7%
Granulocytes 0.73 0.53 5.3% 0.72 0.52 5.4% 0.72 0.52 5.4% 0.72 0.52 5.4% 0.71 0.50 5.5% 0.73 0.52 5.4%
Monocytes 0.52 0.27 2.0% 0.54 0.29 2.0% 0.51 0.25 2.0% 0.53 0.27 2.0% 0.53 0.28 1.9% 0.54 0.29 2.0%
r: correlation coefficient.
R2: coefficient of determination.
rMSE: root mean square error for the residuals from the linear regression model.
Figure 3. Quantile-quantile plot of the log10 (P values) for the epigenome-wide association of gestational age at birth among models adjusted for cell type composition
using the adult reference methylation panel, the direct clinically measured cell types, and the cord blood reference methylation panel.
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of these approaches adequately corrected for differences in dis-
tribution between measured and predicted cell types.
One previous study compared differential cell counts (DCC)
in cord blood using manual microscopy and estimated leuko-
cyte composition using the adult reference panel.5 This study
found no significant correlations between the manual DCC and
the estimated leukocyte composition from the adult reference
panel. In contrast, we observed significant moderate correla-
tions between the adult reference panel estimates and the clini-
cally measured leukocyte composition using an automated
hematological analyzer. It has been shown that the automated
measurement of nucleated cell types using a hematology ana-
lyzer is more accurate than the manual DCC when compared
to fluorescence activated cell sorting (FACS), considered as the
gold standard.9 For example, this study used the same hemato-
logical analyzer used for in our validation and reported a root
mean square error (RMSE) of 1.46% between FACS and the
automated hematological analyzer while the RMSE between the
manual DCC and FACS was 2.99%. The accuracy in cell count
measurement potentially explains the lack of association
between DCC and the adult reference panel estimates previ-
ously reported. However, in this previous study utilizing DCC
the adult reference panel was reported to overestimate the pro-
portion of lymphocytes and monocytes while underestimating
the proportion of granulocytes, consistent with our findings.
A validation study an adult DNA methylation reference
panel reported similar correlations for the estimated and mea-
sured proportions of lymphocytes (r D 0.61) and monocytes
(r D 0.60) as the ones we observed.10 However, this validation
study reported higher agreement between measured and esti-
mated cell types for monocytes and lymphocytes among adults.
One potential explanation for the differences observed is that
the cell type prediction algorithm is based on whole cord blood
DNA methylation that might reflect abundance of other cell
types not isolated or present in the adult or cord blood refer-
ence panels. Other sources of DNA that might not be accurately
captured by the automated hematological clinical analyzer
include apoptotic cells, haematopoietic stem cells, and cell-free
fetal DNA. This is relevant for epidemiological studies as buffy
coat, widely used as a source of DNA in birth cohorts, contains
haematopoietic and progenitors cells.11 Furthermore, it has
been shown that nRBCs can physically interact and adhere to
lymphocytes present in the buffy coat.12
nRBCs have been shown to undergo rapid apoptosis with at
least half of the nRBCs in maternal blood measured during
pregnancy estimated to undergo apoptosis.13 Furthermore, cell
free fetal DNA has been detected across different mammals
and shown to increase with gestational age in some.14 Another
potential source of DNA in cord blood, not included in the
available reference panel, are haematopoietic stem cells, which
are more abundant in cord blood compared to adult blood or
even bone marrow.15 If sufficient amounts of cell-free DNA—
from apoptotic nRBC and other sources—or stem cell DNA are
present in cord blood, estimates from DNA methylation meas-
urements could yield different cell type distributions. However,
we are unable to formally test this hypothesis with our available
data.
Furthermore, in the epigenome-wide association of gesta-
tional age the lowest genomic inflation factor was observed for
the cord blood reference panel even when compared to the
direct cell type measurements. This observation supports our
hypothesis that additional DNA not originated from the 7 iso-
lated cell types might be source of bias observed between the
measured and predicted cell type distributions as the genomic
inflation factor is substantially reduced compared to the direct
or adult reference panel adjustment. Our aim was to evaluate
the impact of cell type adjustment using gestational age as an
example, but we did not systematically describe this association.
Agreement was observed among the Bonferroni significant
CpGs after adjusting for the directly measured cell types and
the new cord blood reference panel but there was no agreement
for the adult reference panel compared to the other 2 cell type
adjustment strategies. Therefore, future studies should evaluate
the relationship between DNA methylation, gestational age,
and cell type composition.
In conclusion, the moderate to high degree of co-variation
between the estimated and measured cell types suggests that
the cord blood reference panel cell composition estimates are
adequate to control for variations in cell type distribution in
epigenome-wide association studies. We also observed an
improvement in the genomic inflation factor as well as the dis-
tribution of P values when adjusting for the estimated cell types
using the cord blood reference panel relative to the adult panel
that is commonly used. However, we caution against using the
distribution of estimated cell type composition to make infer-
ences about immunological parameters in cord blood. Future
studies should develop methodology that quantitatively pre-
dicts cell type distribution in cord blood and further evaluate
the presence of other sources of DNA in cord blood.
Methods
Study population
Mother and infant pairs were participants in the Genetics of
Glucose Regulation in Gestation and Growth (Gen3G), a pro-
spective pre-birth cohort recruited at the Center Hospitalier
Universitaire de Sherbrooke (CHUS) in Canada, described in
detail previously.16 Expecting mothers were recruited during
the first trimester of pregnancy and were eligible for the study
if they were 18 y of age or older, had a singleton pregnancy,
and were not diagnosed with pre-pregnancy diabetes or diabe-
tes during the first trimester. A total of 154 cord blood samples
were available for this analysis with information on both epige-
nome-wide DNA methylation and direct measures of nucleated
white and red blood cells. Study protocols were approved by
the CHUS ethics review board and written informed consent
was obtained from eligible women.
Measurements of nucleated cells in cord blood
We collected fresh samples of cord blood immediately upon
delivery into an EDTA-coated syringe. Samples were trans-
ported within an hour of collection to the CHUS hematology
lab. We measured absolute cell counts in whole cord blood
within an hour and half of sample collection using the XE-
5000TM automated hematology system (Sysmex, Canada, Inc.),
following the manufacturer’s instructions. Briefly, this
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automated hematology analyzer uses scatter light and fluores-
cence labeling information to uniquely differentiate cell types.17
This automated analyzer has been shown to perform well com-
pared to other commercial methods or manual microscopy
evaluations.18 Data were reported for each sample as absolute
counts of nucleated red blood cells (nRBCs), eosinophils, lym-
phocytes, monocytes, neutrophils, and basophils. The propor-
tion of each cell type was calculated as the count of the cell type
divided by the absolute count of all 6 cell types, including
nRCBs. We summed the proportion of basophils, eosinophils,
and neutrophils to compare to values of granulocytes, as esti-
mated by the cord blood reference panel.
DNA methylation and cell type estimates fromminfi
Epigenome-wide DNA methylation measures were performed on
cord blood DNA that was extracted from buffy coat and bisulfite
converted. Samples were run on the Illumina InfiniumHumanMe-
thylation450 BeadChip (Illumina, San Diego, CA). Samples with
more than 5% of probes missing were excluded from the analyses;
sex-mismatch and duplicate samples were also removed prior to
analyses. Samples that passed quality controls were imported into
R via the minfi package in Bioconductor.6 The red-green channel
set raw data object (rgSet) was used to estimate nucleated cell type
distribution using the estimateCellCounts function fromminfi. We
first estimated cell type composition using the newly developed
cord blood reference panel with the default cord blood options,
which together processes the experimental and reference methyla-
tion data using noob and selects 100 probes per cell type regardless
of direction (hyper- or hypo-methylated discriminatory probes can
be selected). We also used the adult reference DNA methylation
panel to estimate cell type composition using the default processing
methods of quantile normalization and selection of 50 hyper- and
50 hypo-methylated discriminatory probes. We further evaluated
the impact of modifying the preprocessing methods by using raw
(unprocessed) methylation values or 5 different normalization
methods available in minfi: Illumina, Noob (cord blood panel
default), FunNorm, Quantile, and SWAN. Lastly, we investigated
the influence of increasing the number of discriminatory probes to
500 or 1000 CpGs, as well as forcing the cord blood panel to select
both hyper- and hypo-methylated probes or selecting discrimina-
tory probes based on F-statistic.
Statistical analysis
We used means and standard deviations (SDs) for numerical
variables or counts and proportions for categorical variables to
describe demographics of the study sample. To estimate the
performance of the prediction for nucleated cell types, we used
Person’s correlation coefficients (r) and simple linear regression
models to estimate the coefficient of determination (R2) as well
as the root mean square error (rMSE) of the residuals for each
estimated cell type. Estimation performance was evaluated
using nucleated cell type composition estimates from the adult
or cord reference panels with multiple normalization methods
for the DNA methylation data. Scatterplots and boxplots are
presented for the estimated and measured proportion of cell
types.
To evaluate the impact of adjusting for cell type composition
estimated via the adult or cord blood reference panels, an epige-
nome-wide association study of gestational age at birth was
conducted. Namely, we used the limma package to fit linear
models of methylation levels for each CpG and gestational age
at birth. Models were adjusted for child sex and estimated cell
type composition using either the adult reference panel cell esti-
mates, the cord blood reference panel cell estimates, or the
directly measured cell type distributions. We compared the
effects of cell type adjustment on model performance by calcu-
lating the genomic inflation factor (λ) for the 2 different analy-
ses as well as plotting QQ-plots and histograms of the P values
for all analyses. All analyses were performed using R 3.3.0
(www.r-project.org/).
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